Effec of Maitland in Shoulder Pathology
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 63
- Locations
- 2
- Primary Endpoint
- Change of Visual Analog Scale (VAS)
Study Overview
Brief Summary
The shoulder is a mobile structure which generates a lot of pathologies. One of them is rotator cuff tendinosis. On the other hand, it has been investigated that Maitland is effective for reducing pain and for mobility in the cervical and lumbar spine and in joints such as the knee and ankle, however, there are few studies that confirm that it is effective in shoulder pathologies.So here the investigatprs want to study the effectiveness of Maitland as an adjunctive treatment for shoulder pathologies, comparing it with conventional physiotherapy treatment, in relation to the reduction of pain and increased mobility. For that the investigators have a randomized clinical trial with two group.
Detailed Description
Group 1 receives tens, SW, conventional physiotherapy and exercises as treatment. Group 2 receives tens, SW, Mailtland, and exercises. An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Have a shoulder pathology.
- •Have a restriction at least of two ranges of movement of the shoulder.
- •Sign the consent before starting the study.
Exclusion Criteria
- •Patients with a history of shoulder or neck surgery.
- •Patients with neurological damage such as stroke or disease of Parkinson's, as well as those with rheumatism, osteoporosis, surgical fixation, or malignant tumors.
- •Have a radiating pain in shoulder from a cervical injury.
- •Pregnant patients.
- •Patients who do not sign the consent before starting the study.
Outcomes
Primary Outcomes
Change of Visual Analog Scale (VAS)
Time Frame: Baseline and 1, 5, and 7 weeks after treatment
Visual analogue score (VAS) was done at rest and at shoulder movement. VAS was explained to the patients during assessment as 0 equal no pain and 10 equal worst imaginable pain.
Change of Disabilities of the Arm, Shoulder and Hand (DASH)
Time Frame: Baseline and 1, 5, and 7 weeks after treatment
Disabilities of the Arm, Shoulder and Hand (DASH) was filled by patient during assessment as 0 equal better functionality and 100 equal worst functionality
Change of Range of Motion (ROM)
Time Frame: Baseline and 1, 5, and 7 weeks after treatment
Active ROM of the affected shoulder is measured using a Mechanic Analysis to assess range of motion. These measurements included abduction, flexion, internal rotation, and external rotation.
Secondary Outcomes
- Change of American shoulder and elbow Surgeons" (ASES)(Baseline and 1, 5, and 7 weeks after treatment)
- Change of 36-Item Health Survey (SF-36)(Baseline and 1, 5, and 7 weeks after treatment)
Investigators
Karishma Chuhermal Lalwani Mangtani
Principal Investigator
University of Las Palmas de Gran Canaria